Menu

Image of the Day: Leprosy Lesion

Researchers identify two blood-clotting proteins that could be biomarkers for cardiovascular reactions in patients with leprosy.

Mar 23, 2018
The Scientist Staff, The Scientist Staff

A vein surrounded by inflammatory cells and fluid, observed in a skin lesion of a leprosy patient FA LARA ET AL.

Some leprosy patients have an elevated risk of developing blood clots that can lead to stroke or heart attack. In a study published yesterday (March 22) in PLOS Neglected Tropical Diseases, researchers identify abnormal levels of several blood clotting factors in leprosy patients that could serve as predictive biomarkers for cardiovascular events.

Flavio Alves Lara, a biologist at the Oswaldo Cruz Institute, and colleagues took blood samples from leprosy patients who had unusually fatty blood clots, which the researchers call “leprosum clots.” They found that patients with leprosum clots had increased levels of a number of different proteins, compared to blood clots from patients who did not have leprosy.

D. Santos da Silva et al., “Blood coagulation abnormalities in multibacillary leprosy patients,” PLOS Negl Trop Dis, doi:10.1371/journal.pntd.0006214, 2018.

 

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Complete Pathology Solutions: Make Every Minute Count

Complete Pathology Solutions: Make Every Minute Count

From sample collection and handling, to fixation and processing, tissue staining, and covering all your IHC and water purification needs—you can have confidence in the quality of your results with MilliporeSigma's one-stop pathology solution.

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.